Bruno Baršić

9.2k total citations · 1 hit paper
103 papers, 3.7k citations indexed

About

Bruno Baršić is a scholar working on Epidemiology, Infectious Diseases and Neurology. According to data from OpenAlex, Bruno Baršić has authored 103 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Epidemiology, 38 papers in Infectious Diseases and 14 papers in Neurology. Recurrent topics in Bruno Baršić's work include COVID-19 Clinical Research Studies (16 papers), Infective Endocarditis Diagnosis and Management (15 papers) and Pneumonia and Respiratory Infections (14 papers). Bruno Baršić is often cited by papers focused on COVID-19 Clinical Research Studies (16 papers), Infective Endocarditis Diagnosis and Management (15 papers) and Pneumonia and Respiratory Infections (14 papers). Bruno Baršić collaborates with scholars based in Croatia, United States and Italy. Bruno Baršić's co-authors include Vance G. Fowler, Arnold S. Bayer, Michael H. Gewitz, Kathryn A. Taubert, Peter B. Lockhart, Anne Fink, Robert S. Baltimore, James M. Steckelberg, Imad M. Tleyjeh and Larry M. Baddour and has published in prestigious journals such as Circulation, Clinical Infectious Diseases and Cochrane Database of Systematic Reviews.

In The Last Decade

Bruno Baršić

94 papers receiving 3.6k citations

Hit Papers

Infective Endocarditis in Adults: Diagnosis, Antimicrobia... 2015 2026 2018 2022 2015 500 1000 1.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bruno Baršić Croatia 21 2.7k 1.8k 1.1k 793 657 103 3.7k
Vivian H. Chu United States 32 2.8k 1.0× 2.2k 1.3× 1.3k 1.2× 985 1.2× 1.1k 1.7× 79 4.2k
James E. Peacock United States 31 1.9k 0.7× 2.4k 1.4× 525 0.5× 505 0.6× 238 0.4× 85 4.0k
Samuel R. Dominguez United States 30 1.4k 0.5× 1.5k 0.8× 350 0.3× 696 0.9× 866 1.3× 105 3.6k
Riad Khatib United States 35 1.1k 0.4× 1.6k 0.9× 657 0.6× 468 0.6× 524 0.8× 128 3.1k
Nabin K. Shrestha United States 33 1.7k 0.6× 1.3k 0.7× 460 0.4× 706 0.9× 454 0.7× 132 3.1k
Emily A. Blumberg United States 44 4.5k 1.6× 2.0k 1.1× 607 0.6× 1.3k 1.7× 220 0.3× 185 7.0k
Manel Almela Spain 36 2.3k 0.8× 2.3k 1.3× 801 0.8× 588 0.7× 184 0.3× 111 4.3k
Jesús Fortün Spain 43 3.6k 1.3× 3.3k 1.9× 484 0.5× 1.0k 1.3× 138 0.2× 194 5.5k
Bernard Rudensky Israel 30 1.1k 0.4× 814 0.5× 573 0.5× 622 0.8× 202 0.3× 131 4.0k
James K. Todd United States 29 1.1k 0.4× 1.5k 0.9× 1.6k 1.5× 543 0.7× 176 0.3× 98 3.7k

Countries citing papers authored by Bruno Baršić

Since Specialization
Citations

This map shows the geographic impact of Bruno Baršić's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruno Baršić with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruno Baršić more than expected).

Fields of papers citing papers by Bruno Baršić

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruno Baršić. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruno Baršić. The network helps show where Bruno Baršić may publish in the future.

Co-authorship network of co-authors of Bruno Baršić

This figure shows the co-authorship network connecting the top 25 collaborators of Bruno Baršić. A scholar is included among the top collaborators of Bruno Baršić based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruno Baršić. Bruno Baršić is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Lucijanić, Marko, et al.. (2023). Incidence, Risk Factors and Mortality Associated with Major Bleeding Events in Hospitalized COVID-19 Patients. Life. 13(8). 1699–1699. 3 indexed citations
3.
Lucijanić, Marko, et al.. (2023). Proton pump inhibitors use prior to COVID-19 hospitalization is associated with higher C lostridioides difficile infection rate. Expert Opinion on Drug Safety. 22(12). 1265–1270.
4.
Skrzydlewska, Elźbieta, Wojciech Łuczaj, Michał Biernacki, et al.. (2023). Preliminary Comparison of Molecular Antioxidant and Inflammatory Mechanisms Determined in the Peripheral Blood Granulocytes of COVID-19 Patients. International Journal of Molecular Sciences. 24(17). 13574–13574.
6.
Žarković, Neven, Lidija Milković, Bruno Baršić, et al.. (2021). Preliminary Findings on the Association of the Lipid Peroxidation Product 4-Hydroxynonenal with the Lethal Outcome of Aggressive COVID-19. Antioxidants. 10(9). 1341–1341. 35 indexed citations
7.
Kotarski, Viktor, et al.. (2017). The use of a single-pass albumin dialysis (SPAD) to correct severe hyperbilirubinemia in Weil's disease: a case report. Hrčak Portal of scientific journals of Croatia (University Computing Centre). 37(1). 19–21.
8.
Kuzman, Ilija, Rok Čivljak, Ivan Puljiz, et al.. (2017). GUIDELINES FOR THE MANAGEMENT OF COMMUNITY-ACQUIRED PNEUMONIA IN ADULTS. Dr Med - University of Zagreb School of Medicine Digital Repository. 139. 0–0. 2 indexed citations
9.
Kutleša, Marko, et al.. (2017). Nosocomial blood stream infections in patients treated with venovenous extracorporeal membrane oxygenation for acute respiratory distress syndrome. Minerva Anestesiologica. 83(5). 493–501. 19 indexed citations
10.
Baddour, Larry M., Walter R. Wilson, Arnold S. Bayer, et al.. (2015). Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications. Circulation. 132(15). 1435–1486. 1919 indexed citations breakdown →
11.
Petrosillo, Nicola, Maddalena Giannella, Massimo Antonelli, et al.. (2013). Clinical Experience of Colistin-Glycopeptide Combination in Critically Ill Patients Infected with Gram-Negative Bacteria. Antimicrobial Agents and Chemotherapy. 58(2). 851–858. 84 indexed citations
12.
Berković, Maja Cigrovski, et al.. (2012). Efficacy and safety of a basal-bolus regimen with insulin glargine in patients with type 2 diabetes after failing premix insulin therapy: a multicenter postmarketing study.. 41(1). 41–48. 3 indexed citations
13.
Kutleša, Marko, Emilija Mlinarić-Missoni, Lóránt Hatvani, et al.. (2012). Chronic fungal meningitis caused by Aureobasidium proteae. Diagnostic Microbiology and Infectious Disease. 73(3). 271–272. 12 indexed citations
14.
Kutleša, Marko, et al.. (2010). Acute Motor Axonal Neuropathy Associated with Pandemic H1N1 Influenza A Infection. Neurocritical Care. 13(1). 98–100. 23 indexed citations
15.
Baršić, Bruno & Ana Pangerčić. (2008). Primjena azitromicina u neregistriranim indikacijama. University of Zagreb University Computing Centre (SRCE). 17. 93–101.
16.
Lepur, Dragan & Bruno Baršić. (2007). Community-Acquired Bacterial Meningitis in Adults: Antibiotic Timing in Disease Course and Outcome. Infection. 35(4). 225–231. 77 indexed citations
17.
Mis̆igoj‐Duraković, Marjeta, Zijad Duraković, & Bruno Baršić. (2005). To exercise or not to exercise in acute upper respiratory tract infections. University of Zagreb University Computing Centre (SRCE). 37(1). 5–12. 1 indexed citations
18.
Krajinović, Vladimir & Bruno Baršić. (2005). Infekcije povezane s centralnim venskim kateterima. 11(59). 115–118.
19.
Baršić, Bruno, Vladimir Krajinović, & Zinka Matković. (2004). Infekcije mokraćnog sustava povezane s urinarnim kateterom. 10(53). 31–35.
20.
Lepur, Dragan, et al.. (2004). Idiopathic Cd4+T-lymphocytopenia—two unusual patients with cryptococcal meningitis. Journal of Infection. 51(2). E15–E18. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026